Simbie AI vs Amgen

Side-by-side comparison of AI visibility scores, market position, and capabilities

Amgen leads in AI visibility (88 vs 39)
Simbie AI logo

Simbie AI

EmergingHealthcare

General

SF EHR-integrated AI voice agent for independent medical practices handling scheduling and insurance verification; YC W25 $500K at 83x revenue growth reducing staff-to-physician ratios by one-third.

AI VisibilityBeta
Overall Score
D39
Category Rank
#439 of 596
AI Consensus
74%
Trend
stable
Per Platform
ChatGPT
44
Perplexity
34
Gemini
42

About

Simbie AI is a San Francisco-based healthcare technology company developing EHR-integrated AI voice agents that serve as 24/7 multilingual administrative staff for independent medical practices — handling scheduling, insurance verification, prescription refill requests, patient communications, and clinical administrative tasks that currently require front-desk staff handling hundreds of calls daily. Founded by Dr. Natalia Khosla and Rachel O'Driscoll and backed by Y Combinator (W25) with $500,000 raised, Simbie achieved 83x revenue growth since its January 2025 launch with zero churn, reducing staff-to-physician ratios by one-third and recovering 10-20% of revenue previously lost to missed calls.

Full profile
Amgen logo

Amgen

LeaderHealthcare Tech

AI Drug Discovery

Amgen (AMGN) reported $33.4B revenue in FY2024, up 19% YoY (post-Horizon acquisition). Top-5 global biotech. 10+ blockbuster drugs. ~24,000 employees. HQ: Thousand Oaks, CA. Market cap ~$130B.

AI VisibilityBeta
Overall Score
A88
Category Rank
#3 of 596
AI Consensus
78%
Trend
stable
Per Platform
ChatGPT
83
Perplexity
87
Gemini
85

About

Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologics and brought landmark medicines including Epogen, Neupogen, and Enbrel to market. The company reported revenues of $33.4B in FY2024, up 19% year-over-year, boosted by the transformational $28B acquisition of Horizon Therapeutics in October 2023.

Full profile

AI Visibility Head-to-Head

39
Overall Score
88
#439
Category Rank
#3
74
AI Consensus
78
stable
Trend
stable
44
ChatGPT
83
34
Perplexity
87
42
Gemini
85
42
Claude
90
36
Grok
92

Key Details

Category
General
AI Drug Discovery
Tier
Emerging
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Amgen
AI Drug Discovery

Integrations

Amgen is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.